Saturday, December 17, 2011

BIOCON LTD - BUY






Biocon is  one of the  largest Biopharmaceutical company in India.Till recently company was mainly concentrating in statins which is a cholesterol lowering drug .But now company is seeking various growth opportunities in other segments and paying much attention for developing  other biotechnology based branded formulations and contract research activities through its subsidiary  Syngene and Clinical research through Clyngene.Branded formulation business is expected to grow about 30% in the coming year.Recently company launched 'INSUPEN' which is a reusable insulin pen.Company's agreement with foreign pharma companies for supply of products are also a positive step.Biocon's overseas operation in the countries like Malaysia ,Germany..etc are also moving in the right direction.Oral insulin is another important step which is going through clinical trials.Biocon's last quarter performance is a tad below expectations but the sharp cut in its share price makes it an attractive buy for long term investors .CMP is Rs.261/-
Posted by VALUEPICK at 5:41 PM
Labels:

20 comments :

  1. AnonymousDecember 18, 2011 at 3:22 AM

    Dear VP,
    What would you suggest to choose between Biocon and Novartis? Novartis price has also come down in recent time.
    Regards
    Girish

    ReplyDelete
  2. AnonymousDecember 18, 2011 at 3:36 AM

    VPJi,

    There has been closure in 2 weaving factories of Mudra? The share has fallen sharply? What is your opinion at this moment?

    Sakharam

    ReplyDelete
  3. AnonymousDecember 18, 2011 at 4:20 AM

    Reason for price falling is one of the partnership drug [BYETTA] having a side effects.[Pancreatic cancer]& its falling below 301/-

    ReplyDelete
  4. VALUEPICKDecember 18, 2011 at 9:07 AM

    Dear Girish

    Novartis is also good for long term investment and already recommended @ Rs.622 .

    See the old link below

    http://value-picks.blogspot.com/2011/02/novartis-india-ltd-buy.html

    ReplyDelete
  5. VALUEPICKDecember 18, 2011 at 9:08 AM

    Dear Sakharam

    That is a matter of cocern

    ReplyDelete
  6. VALUEPICKDecember 18, 2011 at 9:26 AM

    These type problems are common for any big pharma companies .I think it is a chance to buy for long term

    ReplyDelete
  7. AnonymousDecember 18, 2011 at 1:04 PM

    VPji,

    Your pick APW president systems, has a delisting news, I have bought at 140 for long term perspective on your recomendation. What should be you advice on it shall I hold it or book profit?

    Regards,

    Rahul

    ReplyDelete
  8. VALUEPICKDecember 18, 2011 at 5:31 PM

    Dear Rahul

    Since there is not much institutional investors in it,company may get the required shares for de listing .

    ReplyDelete
  9. JatinDecember 19, 2011 at 11:29 AM

    hi vp ,orchid chem @ 115 is not a safe bet ?

    ReplyDelete
  10. sameerDecember 19, 2011 at 3:33 PM

    Dear Valuepick,
    with today's news on FCCB, I thought Orchid Chem should have jumped upwards.but exactely reverse happened. Is it buy for long term at current levels?

    ReplyDelete
  11. VALUEPICKDecember 20, 2011 at 5:42 AM

    Dear Sameer

    Orchid is a long term buy

    ReplyDelete
  12. AnonymousDecember 20, 2011 at 10:46 AM

    DEAR VALUE PICK,

    WHAT'S YOUR OPINION ON ICSA LTD. NOW TRADING @ 24. WHAT S THE MATTER THIS KIND OF SHARP FALLING. CAN I ENTER NOW FOR LONG TERM ?

    SHAHEER THRISSUR

    ReplyDelete
  13. VALUEPICKDecember 20, 2011 at 9:09 PM

    Dear Shaheer

    I am skeptical about ICSA and its published results for a long time.

    ReplyDelete
  14. AnonymousDecember 21, 2011 at 12:33 PM

    dear sir,

    what is your view on jkagrigenetics which came down to decent levels..

    gopi

    ReplyDelete
  15. PraveenDecember 21, 2011 at 2:04 PM

    Can u plz suggest a stock for one month horizon?

    ReplyDelete
  16. aditya kumar singhDecember 21, 2011 at 5:07 PM

    sir do you track tera software, it crash 20% in tommorow's trade. what may be reason

    ReplyDelete
  17. AnonymousDecember 21, 2011 at 5:55 PM

    Dear Sir,

    I am a silent admirer of your analysis and choice of the companies . however I am afraid you have got it wrong in case of Biocon . This company management - although tremendously hyped - has neither the merit not the ethics to become along term success story . Please keep away if you are looking for long term investment .
    for reasons , you can consult any Pharma industry expert.

    ReplyDelete
  18. VALUEPICKDecember 21, 2011 at 9:10 PM

    Dear Gopi

    Uncertainty of the sanction of de-merger is bit worrying about JK Agri

    ReplyDelete
  19. VALUEPICKDecember 21, 2011 at 9:11 PM

    Dear Praveen

    Nothing to suggest for one month

    ReplyDelete
  20. VALUEPICKDecember 21, 2011 at 9:11 PM

    Dear aditya kumar gautam

    Not tracking Tera soft

    ReplyDelete

Subscribe to: Post Comments ( Atom )

Followers

Tweet TopOfBlogs